iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
174.93
-2.51 (-1.41%)
Jan 2, 2026, 1:30 PM EST - Market open
iRhythm Technologies Revenue
iRhythm Technologies had revenue of $192.88M in the quarter ending September 30, 2025, with 30.74% growth. This brings the company's revenue in the last twelve months to $702.57M, up 25.45% year-over-year. In the year 2024, iRhythm Technologies had annual revenue of $591.84M with 20.13% growth.
Revenue (ttm)
$702.57M
Revenue Growth
+25.45%
P/S Ratio
8.03
Revenue / Employee
$351,287
Employees
2,000
Market Cap
5.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
| Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
| Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
| Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
| Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
| Dec 31, 2019 | 214.55M | 67.28M | 45.68% |
| Dec 31, 2018 | 147.28M | 48.15M | 48.57% |
| Dec 31, 2017 | 99.13M | 35.06M | 54.72% |
| Dec 31, 2016 | 64.07M | 27.93M | 77.29% |
| Dec 31, 2015 | 36.14M | 14.39M | 66.17% |
| Dec 31, 2014 | 21.75M | 6.38M | 41.52% |
| Dec 31, 2013 | 15.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IRTC News
- 3 days ago - iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 27 days ago - HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 weeks ago - iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 7 weeks ago - Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC - Business Wire
- 7 weeks ago - iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025 - GlobeNewsWire
- 2 months ago - iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating - Barrons
- 2 months ago - iRhythm Technologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook - Benzinga